申请人:NOSCIRA, S.A.
公开号:EP2527322A1
公开(公告)日:2012-11-28
The present invention is related to compounds of Formula (I), namely novel carbamyl alkylphenyl disulfide derivatives; said compounds for use as a medicament; a pharmaceutical composition comprising said compounds; said compounds for use in the treatment of certain diseases or conditions; the use of said compounds as a reactive in an in vitro biological assay requiring inhibition of GSK-3; the use of said compounds in the preparation of a medicament for the treatment of certain diseases or conditions; and a method of treating a disease, comprising administering said compounds.
本发明涉及式(I)的化合物,即新型的氨基甲酰基烷基苯基二硫化物衍生物;所述化合物用作药物;包含所述化合物的制药组合物;所述化合物用于治疗某些疾病或病况;所述化合物用作体外生物测定中的反应物,需要抑制GSK-3;所述化合物用于制备用于治疗某些疾病或病况的药物;以及一种治疗疾病的方法,包括给予所述化合物。